Results 101 to 110 of about 29,629 (128)

Barnaculate Carcinoma in Four Patients: Verrucoid Squamous Cell Carcinoma Subtype with TERT and HRAS Oncogenic Variants. [PDF]

Head Neck Pathol
Liang Y, Afkhami M, Thompson LDR, Gao H, Maghami EG, D'Apuzzo M, Chang S, Bell D, Telatar M, Gernon TJ, Wu H.   +10 more
europepmc   +1 more source

Unravelling Resistance: Integrating Metabolism, Epigenetics, Immunology, and Proteostasis in Strategies against Kirsten Rat Sarcoma Viral Oncogene Homolog-mutant Colorectal Cancer. [PDF]

Int J Biol Sci
Li J, Song N, Ma R, Qu X.
europepmc   +1 more source

Loss of DNA replication fork protection by TIMELESS degradation supports oncogene-induced senescence. [PDF]

Biochem Biophys Res Commun
Park JJ, Rageul J, Lo N, Patel JA, Talos F, Kim H.   +5 more
europepmc   +1 more source

17-β-Estradiol Protects Chondrocytes From Senescence and Ameliorates Osteoarthritis Progression via ERα-AKT-FOXO4 Pathway. [PDF]

J Cell Mol Med
Liu Y, Ai J, Zhang Z, Lu X, Yu C, Zha Y, Zhang H.   +6 more
europepmc   +1 more source

Regulation of G1/S Cell Cycle Progression by Transforming Growth Factor-beta [PDF]

, 2003
Zhang, Fan
core  

Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review). [PDF]

Oncol Rep
Sharma U, Song J, Kandu H, Zhu Y, Dai Z.
europepmc   +1 more source

The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis. [PDF]

Front Immunol
Hao Y, Liu J, Lou J, Yan J.
europepmc   +1 more source

P21-activated kinase 4: a potent oncogene, molecular mechanisms and opportunities for targeted therapy. [PDF]

Cancer Cell Int
Huang G, Yang Y, Luo Q, Wang X, Wang Y, Liu R, Liu W, Yan S, Li X.   +8 more
europepmc   +1 more source

Functional Analysis of Rare RAS Variants of Unknown Significance. [PDF]

Cancer Res Commun
Park S, Ikegami M, Kitada R, Takamochi K, Suzuki K, Mano H, Kohsaka S.   +6 more
europepmc   +1 more source

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy. [PDF]

PLoS One
Ibraheem W, Alsheikh F, Alzain AA, Bhongade BA, Ejaz L, Baig H, Robinson RC, El-Tanani M.   +7 more
europepmc   +1 more source